Drug Approval | January 19, 2024
Lupin receives USFDA’s approval for Febuxostat Tablets
Febuxostat Tablets (RLD Uloric) had estimated annual sales of US$ 27 million in the U.S. (IQVIA MAT November 2023)
Febuxostat Tablets (RLD Uloric) had estimated annual sales of US$ 27 million in the U.S. (IQVIA MAT November 2023)
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
SÜDPACK customers also benefit when it comes to processing PharmaGuard
Subscribe To Our Newsletter & Stay Updated
